Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
lol Cramer? hes cluelss a day late a dollar short most of the time. Hes good for getting some info not following when to buy and sell. Where was he when we were $13.00 and announced Atria investment? no where to be found. He liked it after it was $22.00 lol. now he sells sell? haha
One thing is for sure hes hoping it goes down. He blew this one terribly
All the wondering what happens when share lockup expires will come to a end soon. Its due Thursday. The weeks ahead will tell the story. I do expect some selling. will there be buyers at this level or does it have to go lower to bring in the volume we need? I don't know for sure. I do know I like this company greatly
Its hard to know what aspect is the greatest plus with Altria taking controls as there are so many. I think they are now attractive for another giant player to come on board soon. We have the potential to move up fast
glta
Cronos MedMen Joint Venture
Although Cronos is making tremendous progress overseas, the company’s most interesting project is close to home: the Cronos MedMen joint venture.
MM Enterprises USA, LLC, also known as MedMen Enterprises, is a U.S. cannabis company with offices in California, Nevada, and New York. Cronos is partnering with MedMen to import U.S. marijuana products into Canada, which seems like a pretty smart move, given Canada’s upcoming legalization on July 1, 2018.
The joint venture will take the name MedMen Canada Inc.
If you live north of the border or are visiting Toronto or Vancouver after July 1, expect to see a ton of MedMen stores and MedMen products. The brand is already quite famous in California—where it has become the largest retail chain in the state—meaning that it has a running head start over the Canadian competition.
“MedMen stores have been integral to mainstreaming cannabis, and they have become one of the most well-known and respected cannabis platforms in the U.S.,” said Cronos CEO Mike Gorenstein. “We’re very excited to bring the MedMen experience to Canada.” (Source: “Cannabis Giants Join Forces in Cross Border Venture,” Cronos Group Inc, March 19, 2018.)
I do agree when Marijuana becomes legal at the federal level in the US or when it even becomes inevitable. Cron will begin to move to a double or more wherever the stock price is at that time. Perhaps even the declassification of the drug will cause this. That's the pathway to legalization
all imo
I do think changes in the banking industry towards Marijuana may happen soon. There was a recent hearing on this. The cannabis sector responded on the legislative hearing
“This hearing was extremely positive and bodes well for the SAFE Banking Act in the current legislative session,” said Morgan Fox, spokesperson for the National Cannabis Industry Association. “Testimony from supporters was wide-ranging and powerful, and the only arguments heard against sensible banking reform consisted of disproved 'gateway' nonsense and jurisdictional arguments, neither of which had anything to do with banking.
I think full legalization is a slim bet at this point. But this is a good start. The legalization of hemp is a pathway for Cron into the US now. It will be interesting exactly what the pathway for them will be
New Senate Bill would legalize Marijuana at the federal level.
https://news.medicalmarijuanainc.com/senate-bill-legalize-marijuana-federal/#
Scroll down for the conference call about the synergy between Atria and Cronos. The potentials that this brings is enormous.
Very exciting week ahead as this becomes official at the shareholders meeting
https://thecronosgroup.com/cronos-group-inc-announces-c2-4-billion-strategic-investment-from-altria-group-inc/
Cronos Israel
While attitudes in this part of the world lean “conservative,” the region’s climate is perfect for growing marijuana. It is warm and dry. Under these conditions, Cronos can manufacture high-quality cannabis for a mere $0.45 per gram, which is vastly better than what it can do here.
However, the company isn’t flying solo in this mission. It enlisted a partner called Gan Shmuel, which is structured as a kibbutz (an Israeli settlement that operates as a socialist village).
This subsidiary already exports to 35 countries in Europe and Asia.
Cronos Australia
One of the company’s most exciting international opportunities is Australia, which has a booming medical marijuana trade and an emerging export business. In fact, CNN reports that Australia wants to become the “world’s number one supplier” of marijuana. (Source: “Australia wants to sell pot to the world,” CNN Money, January 4, 2018.)
Cronos is using its Melbourne office to leverage this opportunity. It has already obtained licenses for cultivation and research. Plus, its 20,000-square-foot facility should be able to produce 2.2 tons of marijuana per year once it’s completed.
Some of this marijuana might be sold in Australia itself, where demand for medical-grade weed is expected to reach $1.0 billion by 2020. However, the rest of Cronos’s production can be shipped overseas to New Zealand and Southeast Asia.
Cronos Germany..remember this news? keep in mind there are shortages of medical MJ in Germany. Also its carried by health insurers
ORONTO, Oct. 12, 2017 /CNW/ - Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) ("Cronos" or the "Company") is pleased to announce that it has entered into a strategic distribution partnership with G. Pohl-Boskamp GmbH & Co. KG ("Pohl-Boskamp"). Founded in 1835, Pohl-Boskamp is an international pharmaceutical manufacturer and supplier, distributing its products to over 12,000 pharmacies in Germany alone.
Under the five-year exclusive distribution agreement, Cronos' global subsidiaries will supply Peace Naturals branded cannabis products to Pohl-Boskamp for distribution within Germany. Leveraging Pohl-Boskamp's extensive distribution network, this partnership provides Cronos with unrivaled access to the German market. Cronos will begin shipping product to Pohl this quarter and will terminate all other existing German supply agreements following this announcement. With over 82 million people and federal insurance coverage for cannabis, Germany is currently the largest legal cannabis market in the world.
"We are ecstatic to partner with Pohl-Boskamp, an established and reputable pharmaceutical leader. This partnership allows us to leverage an existing industry leading pharmaceutical distribution channel to immediately create the world's largest medical cannabis distribution platform," said Mike Gorenstein, CEO of Cronos.
"Pohl has been a reliable partner for pharmacies for many years. Now we are excited to have Cronos as a partner and supplier of cannabis for the German market. With our new partner we are confident that we will provide reliable distribution of cannabis for German patients," Marianne Boskamp, CEO of Pohl-Boskamp.
Cron investors are sitting on a gold mine imo if they can hold through the trading swings to much higher prices. Double very doable perhaps conservative target in the near to mid term.
I think it's a lock not only the investment is accepted but soon Altria Group takes control with their warrant purchase at $19.00. This is going to get the PR machine rolling with their plans. The market loves big tobacco moving into pot.
Active board today. Good to see
I don't think it runs like TLRY either. It can run to 30s 40s though
That would actually be great. Id love to buy in that range again. Im not sitting out waiting for it. Too risky to run away. Just not worth the risk for me personally. Id be sick if it ran to 30's and beyond and I was out looking for cheaper shares. I would take more on in that range.
Really depends on how big one thinks the market is going to be and how much Cron will capture Many investors think the projections are too small for the industry. Imagine that. The power of weed imo will be overwhelming recreationally, medically, and in health and wellness IMO.
I think this is going significantly higher short term. This is a high growth sector unlike we have seen in a long time. Cron has nearly 2 billion at its disposal to acquire and build a infrastructure that makes them the industry leader. Investors and funds love to buy into a high growth company with no dilution foreseeable. This separates Cron from the rest imo, After they go through 2 billion if they need more to continue growth and dominance the stock will be significantly higher.Significant dilution averted and ability to raise billions more.
Not to suggest Cron is anything like amazon but the same things were said in Amazon's infancy. Over valued. its worth 750Billion today. In years Cron can do 50B no problem in market cap. just my opinion
here is where the filings are. https://sedar.com/ search the data base by company name which is Yield Growth. Choose the document "final long form perspectus." I suggest to look at the share issuances as well as the warrants. And at what prices dating back to 2017 to current that they are issued.
draw ones on conclusions.
That is what I got back from IR just today. I read the filings and would concur that's very close. I am going back to read one more time my DD is progressing
This is surely out of date. My understanding is there was a equity raise during the IPO. Financials should be out by the end of March to give a clearer picture on the share structure. Of course their revenues should also be increasing because Urban Juve products started selling in December. basically the info we have to date is out of date
no doubt. Its important that the entire sector does well. At this early stage of the game anyway
That is correct. Q4 earnings expected towards end of March we will get updated.
Tough day. No worries. Retail investors and traders have the jitters in this sector. I can recall the early days of Facebook and Google trading very well. It was no different. I remember the doom and gloom when these were tanking or not performing. You know what ended up happening
I asked IR
they are shooting for 3rd week march. They will update
Pre Market looking good for CW today. The sector as well.
What's most exciting for me is I have believed in this product my entire life. I recall way back in school studying alcohol prohibition. I maintained we are still under a prohibition. It's marijuana. I ended up Writing a thesis on it and presenting it.
That time frame is just about right. This is the exact reason CW has stated they really won't have competition for two years. I see them continuing to control about 14% of this market as they do now. ill take 14% of 10 billion in two years. That's a low ball estimate with industry expecting 22b in three years growth
Going to be exciting watching this all develop a step at a time
As a very big investor in this company now I prefer to see the stock not suffer from this. And it may not. However if it does I will buy more.
Bottom line it won't change the strong potential of experiencing very large gains as the company experiences enormous growth moving forward
This is the response from IR about the share lockup. Its really the way I see it too.
"Thank you for your comments
The lock-up comes due Feb 25.
There may or may not be some volatility surrounding the date but this does not affect the long term prospects of the company either way.
We are managing the process."
You nailed it Charlottes business model is set to experience enormous growth over the next two years. They are focused. At that point My bet is they will move more into being a medical company vs health and wellness. Could even move heavily into recreational if the the laws support that. They can capture the greater market share of Health and wellness over the next two years. Which is anticipated to be 22B dollars in itself. This is our focus and its happening. If they continue to control 14% of the market as they do now. Well do the math. 1 billion worst case to 2 Billion revenues. They are well positioned to be the biggest company in that field. Then the business model moves in other directions too if not sooner
Our New Chief Operating Officer. Stephen Lermer
President
PharmaForm LLC operates as a contract manufacturer in the areas of pharmaceutical dosage form development. It specializes in controlled release and bioavailability enhancement technologies, such as hot melt extrusion, fluid bed processing, liquid filled capsules, and spray drying. The company was founded by Robert O. Williams III and is headquartered in Austin, TX.
Senior Vice President-Manufacturing
Akela Pharma, Inc.
Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX.
Other affiliations and executive positions held
Stephen Lermer is affiliated with Charlotte's Web Holdings, Inc., PharmaForm LLC, Akela Pharma, Inc., Aravas, Inc., Auxilium Pharmaceuticals LLC, Orion Pharma Oy, Rhone-Poulenc Rorer Central Research, Johnson & Johnson, Warner-Lambert Co., Rhône-Poulenc, Inc., Burroughs Wellcome, DuPont
I feel you on this. People will buy hemp products regardless of FDA
However The FDA can be our greatest friends. They want to get involved in hemp. They want a piece of this. Products will become FDA approved. I see CWBHF well positioned to be the first and certainly of the first ones. Great to have a Big pharm exec on board
amazing things to come
exactly. So far not getting this respect. And the fact that their revenues are big and growing fast. Its not a story stock.
The time will come
There is going to be a lot of negative noise along the way. I will be sticking to what I believe is a miracle drug in a lot of ways. One that has been prohibited. Those days are fast leaving finally. The people want it worldwide
Believing in the powers of weed will make it much easier to ride this roller coaster. We are at the very beginning of something very big in the health industry. That alone is massive. It also is going to be big recreationally. Quite a unique drug
As we move forward research is going to be moving at a much faster pace now. We will find some amazing health uses we have not discovered yet
I have been reading this board. I researched everywhere looking for a company that was cheaply valued in this sector yet could be one of the big players. I found two so far, this is the one I went for since its all legal and geared to medical. Their financials passed the test as well
Thanks to all the contributors for your time its been helpful. I am building a very large position in IRA accounts. This is going to be a very wild ride. Assuming this company is one of the top few the key to making big $$ is holding through massive swings. Also Adding on dips and holding big gains. Daily values should be of little concern
One could be a great trader too but my experience has told me the investor minded person is the big winner in the end. If you got the right one!